MYOSIN THERAPEUTICS INC.

Profile

Company Names

MYOSIN THERAPEUTICS INC.

Addresses

130 SCRIPPS WAY, 3B3, JUPITER, FL 33458

Phone Numbers

1-844-696-7469

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$2,999,986.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-12-02 
$2,999,986.00 
$2,999,986.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVE 
 
ADAMS 
DIRECTOR
HORSETAIL TECHNOLOGIES, LLC   |  MYOSIN THERAPEUTICS INC.   |  NOXX THERAPEUTICS, INC.
ROBERT 
 
FINIZIO 
DIRECTOR
VITAMEDMD, LLC   |  ZYVERSA THERAPEUTICS, INC.   |  PLEOPHARMA L.L.C.   |  PLEOPHARMA, INC.   |  MYOSIN THERAPEUTICS INC.   |  NOXX THERAPEUTICS, INC.
PATRICK 
 
GRIFFIN, PH.D. 
DIRECTOR
MYOSIN THERAPEUTICS INC.
THEODORE 
 
KAMENECKA 
DIRECTOR
MYOSIN THERAPEUTICS INC.
COURTNEY 
 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
MYOSIN THERAPEUTICS INC.
ANDREW 
 
RITTER 
DIRECTOR
RITTER PHARMACEUTICALS INC   |  MYOSIN THERAPEUTICS INC.   |  GT BIOPHARMA, INC.
JACKSON 
 
STREETER 
DIRECTOR
BANYAN BIOMARKERS, INC.   |  LUMITHERA, INC.   |  ASTROCYTE PHARMACEUTICALS INC.   |  MYOSIN THERAPEUTICS INC.   |  OPZIRA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-03-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-02 
2022-12-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#